To Severe Persistent Asthma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-03-29
Clinical Trial Update: Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation [Phase 2]
Phase 2 trial update on CBP-201 for moderate to severe persistent asthma with Type 2 inflammation reports efficacy and safety results.